Source: Eur Respir J 2011; 37: 1447-1452
Disease area: Respiratory infections



Rating:

Share or cite this content

Citations should be made in the following way:
Lee S.W., Oh D.K., Lee S.H., Kang H.Y., Lee C-T., Yim J-J.. Time interval to conversion of interferon-? release assay after exposure to tuberculosis. Eur Respir J 2011; 37: 1447-1452

Member's Comments

No comment yet.

Related content which might interest you: Cost-effectiveness of interferon-γ release assay testing for the treatment of latent tuberculosis Source: Eur Respir J 2007; 30: 321-332 Year: 2007 Quantitative scoring of an interferon-γ assay for differentiating active from latent tuberculosis Source: Eur Respir J 2007; 30: 722-728 Year: 2007 Direct costs of three models for the screening of latent tuberculosis infection Source: Eur Respir J 2006; 28: 45-50 Year: 2006 Avoiding the effect of BCG vaccination in detecting Mycobacterium tuberculosis infection with a blood test Source: Eur Respir J 2006; 28: 16-23 Year: 2006 Interferon-gamma release assays in tuberculosis contacts: is there a window period? Source: Eur Respir J 2011; 37: 215-217 Year: 2011 Can we predict who will develop TB among those with a positive interferon-? release assay (IGRA)? Source: International Congress 2018 – Important changes in the management of tuberculosis Year: 2018 Interferon-? release assays for the diagnosis of latent Mycobacterium tuberculosis infection Source: Eur Respir J 2011; 38: 1238-1239 Year: 2011 What is the best test to detect latent tuberculosis infection in sarcoidosis patients? – Comparison between two commercially available interferon gamma release assays Source: Annual Congress 2013 –Diffuse parenchymal lung disease III Year: 2013 TB as an occupational disease Source: Eur Respir Mon 2012; 58: 219-229 Year: 2012 Serial interferon-gamma release assays for screening and monitoring of tuberculosis infection during treatment with biologic agents Source: Annual Congress 2013 –Tuberculosis and latent tuberculosis infection in subpopulations Year: 2013 Tuberculin skin test or interferon gamma release assay - How to detect latent tuberculosis infection in sarcoidosis patients? Source: International Congress 2015 – Sarcoidosis: clinical Year: 2015 Additional analysis of antigen-specific Interleukin-2 release does not improve the performance of IGRAs for the differentiation of different states of mycobacterium tuberculosis infection Source: International Congress 2014 – Future frontiers in the diagnosis of Mycobacterium tuberculosis infection Year: 2014 Serial interferon-gamma release assay in children with tuberculosis infection Source: Annual Congress 2010 - Tuberculosis in children Year: 2010 Interferon-gamma release assays (IGRA) for latent tuberculosis infection (LTBI) in children Source: Annual Congress 2011 - Tuberculosis in pregnancy and childhood Year: 2011 Use of a T-cell-based test for detection of tuberculosis infection among immunocompromised patients Source: Eur Respir J 2006; 28: 31-34 Year: 2006 Relationship of immunodiagnostic assays for tuberculosis and numbers of circulating CD4+ T-cells in HIV infection Source: Eur Respir J 2010; 35: 619-626 Year: 2010 LTBI: latent tuberculosis infection or lasting immune responses to M. tuberculosis? A TBNET consensus statement Source: Eur Respir J 2009; 33: 956-973 Year: 2009 A combinatorial dual-immunoassay predicts reactivation risk for patients with previously incomplete treatment for latent tuberculosis infection Source: International Congress 2016 – Active and latent tuberculosis: biomarkers Year: 2016 Omics and single molecule detection: the future of TB diagnostics Source: Eur Respir Mon 2012; 58: 144-153 Year: 2012 Impact of interferon-? release assay on the latent tuberculosis cascade of care: a population-based study Source: Eur Respir J , 49 (3) 1601546; DOI: 10.1183/13993003.01546-2016 Year: 2017